Keybank National Association Grifols Sa Transaction History

Keybank National Association

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 05, 2020	SELL	$19.57 - $23.52 $789,747 - $949,149	-40,355 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$19.85 - $22.76 $39,402 - $45,178	-1,985 Reduced 4.69%	40,355 $809,000
Q2 2019 Aug 01, 2019	SELL	$17.59 - $21.1 $3,922 - $4,705	-223 Reduced 0.52%	42,340 $893,000
Q1 2019 May 08, 2019	SELL	$18.01 - $20.11 $17,307 - $19,325	-961 Reduced 2.21%	42,563 $856,000
Q4 2018 Jan 30, 2019	SELL	$17.44 - $21.53 $57,255 - $70,682	-3,283 Reduced 7.01%	43,524 $799,000
Q3 2018 Nov 08, 2018	BUY	$19.97 - $21.96 $73,170 - $80,461	3,664 Added 8.49%	46,807 $1 Million
Q2 2018 Aug 08, 2018	SELL	$20.16 - $24.68 $14,958 - $18,312	-742 Reduced 1.69%	43,143 $928,000
Q1 2018 May 15, 2018	BUY	$20.31 - $24.95 $5,564 - $6,836	274 Added 0.63%	43,885 $930,000
Q4 2017 Feb 08, 2018	BUY	$20.99 - $23.89 $13,937 - $15,862	664 Added 1.55%	43,611 $1 Million
Q3 2017 Nov 02, 2017	SELL	$20.07 - $21.89 $3,271 - $3,568	-163 Reduced 0.38%	42,947 $940,000
Q2 2017 May 14, 2018	BUY	N/A	1,124 Added 2.68%	43,110 $911,000
Q1 2017 May 14, 2018	SELL	N/A	-3,130 Reduced 6.94%	41,986 $792,000
Q4 2016 May 14, 2018	BUY	N/A	45,116	45,116 $725,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.75B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.